{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:17:14Z","timestamp":1778876234494,"version":"3.51.4"},"reference-count":56,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"5","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Patients with breast cancer in Ethiopia are generally diagnosed with late-stage disease, and there is a high proportion of young female and male patients. The role of genetic predisposition is yet unknown in this setting. To increase the knowledge about hereditary breast cancer in Ethiopia, this study investigated germline pathogenic variants (PVs) in breast cancer\u2013predisposing genes in a high-risk cohort of young women and men with breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>\n                      One hundred women (age 18-39) and men (all ages) diagnosed with breast cancer at the Tikur Anbessa Specialized Hospital, Addis Ababa, were included. Basic patient and tumor characteristics, and family history were collected, and blood samples drawn. DNA was extracted locally before transport to Lund University, Sweden, for DNA analysis using next-generation sequencing. Type and frequency of PVs in breast cancer\u2013related genes (\n                      <jats:italic toggle=\"yes\">ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                      ) were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      A high proportion of the 89 study participants with successful genetic analysis carried PVs in breast cancer susceptibility genes (23.6%; 95% CI 15.2 to 33.8). In total, 22 PVs were detected in\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      (n = 7),\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      (n = 8),\n                      <jats:italic toggle=\"yes\">PALB2<\/jats:italic>\n                      (n = 4),\n                      <jats:italic toggle=\"yes\">BARD1<\/jats:italic>\n                      (n = 1),\n                      <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                      (n = 1), and\n                      <jats:italic toggle=\"yes\">ATM<\/jats:italic>\n                      (n = 1). Potential founder variants and two novel PVs were found (\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      c.5278-864_5332+621del and\n                      <jats:italic toggle=\"yes\">PALB2<\/jats:italic>\n                      c.1169_1170del).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Genetic predisposition plays an important role among young women and men in the study setting, with nearly one in four patients carrying a PV. The results call for further research and interventions targeting individuals at high risk, with the long-term potential of reduced morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00699","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:59:15Z","timestamp":1778875155000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Germline Pathogenic Variants in Breast Cancer\u2013Predisposing Genes Among Early-Onset Female and Male Breast Cancer in Ethiopia"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-7025","authenticated-orcid":true,"given":"Tove","family":"Ekdahl Hjelm","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Oncology, S\u00f6dersjukhuset, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tewodros Yalew","family":"Gebremariam","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, College of Health Sciences, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahlet Fekadu","family":"Weldearegay","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, College of Health Sciences, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6114-638X","authenticated-orcid":true,"given":"Bethlehem Getachew","family":"Ayele","sequence":"additional","affiliation":[{"name":"Department of Oncology, School of Medicine, College of Health Sciences, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-8846","authenticated-orcid":true,"given":"Mathewos","family":"Assefa","sequence":"additional","affiliation":[{"name":"Department of Oncology, School of Medicine, College of Health Sciences, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endale","family":"Anberber","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, College of Health Sciences, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1358-0695","authenticated-orcid":true,"given":"Anders","family":"Kvist","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-3107","authenticated-orcid":true,"given":"Therese","family":"T\u00f6rngren","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-132X","authenticated-orcid":true,"given":"\u00c5ke","family":"Borg","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5526-5570","authenticated-orcid":true,"given":"Sara","family":"Margolin","sequence":"additional","affiliation":[{"name":"Department of Oncology, S\u00f6dersjukhuset, Stockholm, Sweden"},{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-7569","authenticated-orcid":false,"given":"Annika","family":"Lindblom","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senait","family":"Ashenafi","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, College of Health Sciences, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-0369","authenticated-orcid":true,"given":"Jenny","family":"L\u00f6fgren","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_7_3_2","volume-title":"NKBC Register Report 2024","author":"Swedish National Quality Register for Breast Cancer (NKBC)","year":"2024","unstructured":"Swedish National Quality Register for Breast Cancer (NKBC): NKBC Register Report 2024. Stockholm, Sweden, Regional Cancer Centers in Cooperation, 2024. https:\/\/statistik.incanet.se\/brostcancer\/"},{"key":"e_1_3_7_4_2","volume-title":"Surveillance, Epidemiology, and End Results (SEER) Program: Cancer Stat Facts: Female Breast Cancer, 2015-2021","author":"National Cancer Institute","year":"2024","unstructured":"National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program: Cancer Stat Facts: Female Breast Cancer, 2015-2021. Bethesda, MD, National Institutes of Health, 2024. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225039"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0299-5"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30259-5"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30261-8"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219601"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14614-x"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac127"},{"key":"e_1_3_7_12_2","unstructured":"Reference deleted"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2018.1529428"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143535"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/301749"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.004"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/747318"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.5922"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.5844"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2956"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913948"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005936"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30498"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23804"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2023.12.001"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0506"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-024-00446-4"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-021-00255-z"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06557-9"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.2059"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.06.010"},{"key":"e_1_3_7_33_2","first-page":"CD002748","article-title":"Risk-reducing mastectomy for the prevention of primary breast cancer","volume":"4","author":"Carbine NE","year":"2018","unstructured":"Carbine NE, Lostumbo L, Wallace J, et al: Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev 4:CD002748, 2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1465"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.09.159"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30447-2"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30111-6"},{"key":"e_1_3_7_38_2","volume-title":"National Guideline for Breast Health, Early Diagnosis and Timely Breast Cancer Management in Ethiopia (2024-2028)","author":"Ministry of Health Ethiopia","year":"2024","unstructured":"Ministry of Health Ethiopia: National Guideline for Breast Health, Early Diagnosis and Timely Breast Cancer Management in Ethiopia (2024-2028). Addis Ababa, Ethiopia, Ministry of Health, 2024"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09137-y"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02107-5"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11229-y"},{"key":"e_1_3_7_42_2","volume-title":"Clinical Genome Resource (ClinGen) Cancer Gene Registry: Variant Curation Expert Panels (VCEPs)","unstructured":"Clinical Genome Resource (ClinGen) Cancer Gene Registry: Variant Curation Expert Panels (VCEPs). https:\/\/clinicalgenome.org\/affiliation\/vcep\/"},{"key":"e_1_3_7_43_2","volume-title":"ClinGen ENIGMA BRCA1: BRCA2 Expert Panel: Specifications to the ACMG\/AMP Variant Interpretation Guidelines for BRCA1 (Version 1.2.0)","year":"2024","unstructured":"ClinGen ENIGMA BRCA1: BRCA2 Expert Panel: Specifications to the ACMG\/AMP Variant Interpretation Guidelines for BRCA1 (Version 1.2.0). Bethesda, MD, Clinical Genome Resource, 2024"},{"key":"e_1_3_7_44_2","volume-title":"ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel: Specifications to the ACMG\/AMP Variant Interpretation Guidelines for BRCA2 (Version 1.2.0)","year":"2024","unstructured":"ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel: Specifications to the ACMG\/AMP Variant Interpretation Guidelines for BRCA2 (Version 1.2.0). Bethesda, MD, Clinical Genome Resource, 2024, https:\/\/cspec.genome.network\/cspec\/ui\/svi\/doc\/GN092"},{"key":"e_1_3_7_45_2","volume-title":"National Center for Biotechnology Information: Breast cancer type 2 susceptibility protein [Homo sapiens], Accession NP_000050.2","year":"2024","unstructured":"National Center for Biotechnology Information: Breast cancer type 2 susceptibility protein [Homo sapiens], Accession NP_000050.2. Bethesda, MD, National Library of Medicine, 2024. http:\/\/www.ncbi.nlm.nih.gov\/protein\/NP_000050.2"},{"key":"e_1_3_7_46_2","volume-title":"ClinGen Hereditary Breast, Ovarian and Pancreatic Cancer Expert Panel: Specifications to the ACMG\/AMP Variant Interpretation Guidelines for PALB2 (Version 1.1.0)","year":"2024","unstructured":"ClinGen Hereditary Breast, Ovarian and Pancreatic Cancer Expert Panel: Specifications to the ACMG\/AMP Variant Interpretation Guidelines for PALB2 (Version 1.1.0). Bethesda, MD, Clinical Genome Resource, 2024. https:\/\/cspec.genome.network\/cspec\/ui\/svi\/doc\/GN051"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-04791-1"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2023.45.188.21616"},{"key":"e_1_3_7_49_2","first-page":"100439","article-title":"Advancing genetic services in African healthcare: Challenges, opportunities, and strategic insights from a scoping review","volume":"6","author":"Kamga KK","year":"2025","unstructured":"Kamga KK, Marlyse PF, Nguefack S, et al: Advancing genetic services in African healthcare: Challenges, opportunities, and strategic insights from a scoping review. HGG Adv 6:100439, 2025","journal-title":"HGG Adv"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-111522-013953"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-018-04897-6"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.3977"},{"key":"e_1_3_7_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1500"},{"key":"e_1_3_7_54_2","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00140"},{"key":"e_1_3_7_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23712-w"},{"key":"e_1_3_7_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.01.008"},{"key":"e_1_3_7_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28691"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:59:21Z","timestamp":1778875161000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1200\/GO-25-00699"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00699","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500699"}}